Molecular Hybridization as a Tool in the Design of Multi-target Directed Drug Candidates for Neurodegenerative Diseases
Молекулярная гибридизация как инструмент разработки мультицелевых лекарственных кандидатов для лечения нейродегенеративных заболеваний
2019-10-21
SCID: 54.1/ggz98sth
Discuss with AI
molecular hybridizationmultifunctional drug candidatesmultitarget-directed ligandsneurodegenerative diseasespolypharmacology
Figures from the paper
Abstract (AI)
Neurodegenerative Diseases (NDs) are progressive multifactorial neurological pathologies related to neuronal impairment and functional loss from different brain regions. Currently, no effective treatments are available for any NDs, and this lack of efficacy has been attributed to the multitude of interconnected factors involved in their pathophysiology. In the last two decades, a new approach for the rational design of new drug candidates, also called multitarget-directed ligands (MTDLs) strategy, has emerged and has been used in the design and for the development of a variety of hybrid compounds capable to act simultaneously in diverse biological targets. Based on the polypharmacology concept, this new paradigm has been thought as a more secure and effective way for modulating concomitantly two or more biochemical pathways responsible for the onset and progress of NDs, trying to overcome low therapeutical effectiveness. As a complement to our previous review article (Curr. Med. Chem. 2007, 14 (17), 1829-1852. https://doi.org/10.2174/092986707781058805), herein we aimed to cover the period from 2008 to 2019 and highlight the most recent advances of the exploitation of Molecular Hybridization (MH) as a tool in the rational design of innovative multifunctional drug candidate prototypes for the treatment of NDs, specially focused on AD, PD, HD and ALS.
Key Findings
1
Molecular hybridization is presented as a rational strategy for designing multifunctional drug candidates that act on diverse biological targets.
2
Multitarget-directed ligands use polypharmacology to modulate multiple biochemical pathways simultaneously, potentially improving therapeutic effectiveness in neurodegenerative diseases.
3
Neurodegenerative diseases involve interconnected multifactorial mechanisms, contributing to the lack of effective treatments.
4
The approach aims to overcome the limited efficacy of single-target therapies by combining activities relevant to neurodegenerative disease pathophysiology.
5
The review surveys molecular-hybridization advances from 2008 to 2019, focusing on candidate prototypes for Alzheimer’s, Parkinson’s, Huntington’s, and amyotrophic lateral sclerosis.
Research Object
molecularly hybridized multifunctional drug candidate prototypes for neurodegenerative diseases, especially Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, and amyotrophic lateral sclerosis
Research Subject
the rational design and development of multitarget-directed ligands that concomitantly modulate multiple biochemical pathways and targets involved in the onset and progression of neurodegenerative diseases
Publication Details
Publication Date
2019-10-21
Journal
Publisher
ISSN
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest